These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35797718)

  • 21. Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.
    Raskin P; Lewin A; Reinhardt R; Lyness W;
    Diabetes Obes Metab; 2009 Sep; 11(9):865-73. PubMed ID: 19476470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method Greenness Profile Assessment to AQbD-Driven Stability Indicating HPTLC Method for Estimation of Aripiprazole Using Screening Design and Response Surface Modeling.
    Prajapati P; Gandhi A; Shah S
    J AOAC Int; 2023 Mar; 106(2):501-513. PubMed ID: 36073908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
    El-Zaher AA; Elkady EF; Elwy HM; Saleh MA
    J AOAC Int; 2016 Jul; 99(4):957-963. PubMed ID: 27214744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.
    Raskin P; Lewin A; Reinhardt R; Lyness W;
    Diabetes Obes Metab; 2009 Oct; 11(10):947-52. PubMed ID: 19531054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deduction of the operable design space of RP-HPLC technique for the simultaneous estimation of metformin, pioglitazone, and glimepiride.
    Marie AA; Hammad SF; Salim MM; Elkhodary MM; Kamal AH
    Sci Rep; 2023 Mar; 13(1):4334. PubMed ID: 36928591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs.
    McGettigan P; Roderick P; Mahajan R; Kadam A; Pollock AM
    PLoS Med; 2015 May; 12(5):e1001826; discussion e1001826. PubMed ID: 25965416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes.
    Comaschi M; Demicheli A; Di Pietro C; Bellatreccia A; Mariz S;
    Diabetes Technol Ther; 2007 Aug; 9(4):387-98. PubMed ID: 17705695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.
    Culy CR; Jarvis B
    Drugs; 2001; 61(11):1625-60. PubMed ID: 11577798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Sensitive HPTLC Method for the Estimation of Glibenclamide, Rosiglitazone Maleate and Metformin Hydrochloride from a Multicomponent Dosage Form.
    Bhende SD; Varanasi MB; Abbulu K
    J Chromatogr Sci; 2020 Apr; 58(5):418-426. PubMed ID: 32086517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green and Sustainable Analytical Chemistry-Driven Chromatographic Method Development for Stability Study of Apixaban Using Box-Behnken Design and Principal Component Analysis.
    Prajapati P; Rajpurohit P; Pulusu VS; Shah S
    J Chromatogr Sci; 2024 Aug; 62(7):649-659. PubMed ID: 37151114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principles of White Analytical Chemistry and Design of Experiments to Development of Stability-Indicating Chromatographic Method for the Simultaneous Estimation of Thiocolchicoside and Lornoxicam.
    Prajapati P; Pulusu VS; Shah S
    J AOAC Int; 2023 Nov; 106(6):1654-1665. PubMed ID: 37462527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples.
    Martín J; Buchberger W; Santos JL; Alonso E; Aparicio I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():94-101. PubMed ID: 22483984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.
    Perez A; Zhao Z; Jacks R; Spanheimer R
    Curr Med Res Opin; 2009 Dec; 25(12):2915-23. PubMed ID: 19827910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.
    Derosa G; Cicero AF; Franzetti IG; Querci F; Carbone A; Piccinni MN; D'Angelo A; Fogari E; Maffioli P
    Diabetes Technol Ther; 2013 Mar; 15(3):214-22. PubMed ID: 23427864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
    Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
    Jovanovic L; Hassman DR; Gooch B; Jain R; Greco S; Khutoryansky N; Hale PM
    Diabetes Res Clin Pract; 2004 Feb; 63(2):127-34. PubMed ID: 14739053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy.
    Panikar V; Chandalia HB; Joshi SR; Fafadia A; Santvana C
    J Assoc Physicians India; 2003 Nov; 51():1061-4. PubMed ID: 15260389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemometric and DoE-Based Analytical Quality Risk Management to HPTLC Method for Simultaneous Estimation of Metronidazole and Norfloxacin.
    Prajapati PB; Patel PR; Shah SA
    J Chromatogr Sci; 2023 May; 61(5):428-439. PubMed ID: 35022688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of costs for four oral antidiabetic regimens within a managed care population.
    Stockl K; Vanderplas AM; Nicklasson L
    Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meglitinide analogues in the treatment of type 2 diabetes mellitus.
    Landgraf R
    Drugs Aging; 2000 Nov; 17(5):411-25. PubMed ID: 11190420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.